Leading haematologist Dr George Grigoriadis was recently awarded a
prestigious Victorian Cancer Agency Clinical Research Fellowship for his ongoing
research into the role of inflammation in the different
stages of myelodysplastic syndromes.
The competitive grant of $800,000 over four
years will also enable Dr Grigoriadis to identify patients who may benefit from
treatment with anti-inflammatory agents.